Contents
- 1 Paid Clinical Trials in Denver
- 2 Demographic Data Reveals Availability in Denver
- 3 Interpreting Denver Demographic Information to Identify Paid Trials
- 4 Denver CROs Healthy Participants Might Explore For Opportunities
- 5 Medical Trends in Denver That Have Influenced the Science
- 6 Denver CRO Trial Opportunities Healthy Volunteers Might Want to Consider
Paid Clinical Trials in Denver
Denver, the mile-high city, is one of the most trending locales in the United States presently. There are those who compare it to Los Angeles; and indeed, when you consider property expenses and the cost of living, it’s easy to see the comparison. Put it this way: $6k in Denver buys what $6.9k in Los Angeles would, according to this link. This indicates something else: Denver locals need additional income. One option they’re turning to is paid clinical trials for healthy volunteers nearby. In Denver, quite a few alternatives exist in this area.
In order to narrow down the sort of opportunities you can expect in Denver, three factors need to be considered. One, how many Clinical Research Organizations (CRO) are in the local region? Two, what is the population of the city and the Combined Statistical Area (CSA) immediately surrounding it, and three, what is the threshold of experimentation necessary on an ongoing basis to maintain medical advances in America?
Well, there are approximately 111 CROs in Denver and the CSA, and the rate of experimentation necessary to maintain ongoing medical advances is roughy 1 out of 200. In Denver, there are approximately 738,594 people within city limits as of 2022, and in the CSA are approximately 3,623,560. This indicates a range of 3,692 to 18,117 individual opportunities in Denver and the CSA, or approximately 33 to 163 individual opportunities per CRO. Remember, most studies involve multiple participants for test and control groups over time.
Demographic Data Reveals Availability in Denver
In order to narrow down the particular paid clinical trials nearby for healthy volunteers you’ll be eligible to participate in, explore Denver demographics. In the city proper, 72.24% of the population is white, 9.18% of the population is black or of African descent, 7.08% of the population are 2 or more races, and 6.95% are another race of indefinite ethnic definition. The median age is 34.6, 49.9% of the population are female, and 50.10% are male.
Consent for Use of Stored Patient Specimens for Future Testing
Recruiting
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic testing.
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic testing. Read Less
Gender:
ALL
Ages:
All
Trial Updated:
09/20/2024
Locations: Univ of Southern California / LA County USC Med Ctr, Los Angeles, California
Univ of Colorado Health Sciences Ctr, Denver, Colorado
Conditions: HIV Infections
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)
Recruiting
The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis. Finding the genes that cause pulmonary fibrosis is the first step at developing better methods for early diagnosis and improved treatment for pulmonary fibrosis. The overall hypothesis is that inherited genetic factors predispose individuals to develop pulmonary fibrosis... Read More
The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis. Finding the genes that cause pulmonary fibrosis is the first step at developing better methods for early diagnosis and improved treatment for pulmonary fibrosis. The overall hypothesis is that inherited genetic factors predispose individuals to develop pulmonary fibrosis. Read Less
Gender:
ALL
Ages:
All
Trial Updated:
09/11/2020
Locations: University of Colorado Denver, Aurora, Colorado
National Jewish Health and University of Colorado Denver, Denver, Colorado
Conditions: Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis, Idiopathic Interstitial Pneumonia, Familial Interstitial Pneumonia
The Immune System's Response to Young Women's Breast Cancer
Recruiting
This study plans to learn more about the immune system's response to breast cancer in young women.
This study plans to learn more about the immune system's response to breast cancer in young women. Read Less
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
12/06/2024
Locations: University of Colorado Denver, Aurora, Colorado +1 locations
Denver Health Hospital Authority, Denver, Colorado
UCHealth Cherry Creek Medcial Center, Denver, Colorado
Conditions: Breast Cancer, Breast Cancer and Pregnancy
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
Recruiting
This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems.
This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems. Read Less
Gender:
ALL
Ages:
All
Trial Updated:
04/17/2024
Locations: Children's of Alabama, Birmingham, Alabama
Presbyterian / St. Luke's Medical Center, Denver, Colorado
Conditions: Infusion Reactions
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Recruiting
XLPAD is an observational study designed to evaluate the effectiveness and use of stent and non-stent based therapies among PAD patients. The study will create a registry that will include entry of procedural and clinical follow-up information into an online data collection software, REDCAP.Data available since Jan 1 2005 will be included in the registry, until 14,000 patients have been included. The primary objectives of this observational registry study are to:
1. Compare stent and non-stent... Read More
XLPAD is an observational study designed to evaluate the effectiveness and use of stent and non-stent based therapies among PAD patients. The study will create a registry that will include entry of procedural and clinical follow-up information into an online data collection software, REDCAP.Data available since Jan 1 2005 will be included in the registry, until 14,000 patients have been included. The primary objectives of this observational registry study are to:
1. Compare stent and non-stent based outcomes defined as a composite of symptom driven target vessel revascularization (TVR), unplanned surgical revascularization of the target limb and need for target limb amputation through 12 months post-index procedure (Primary efficacy endpoint)
2. Compare stent and non-stent based outcomes defined as a composite of causes such as: death, myocardial infarction (MI), stroke, peri-procedural complications, target vessel revascularization (TVR) and unplanned surgical revascularization/amputation of the target limb through 12 months (Primary safety endpoint)
3. Compare stent and non-stent based change in walking distance, Rutherford category and/or ankle- brachial index (ABI) at 12 months compared to baseline (Primary clinical improvement endpoint)
Approximately 14,000patients will be enrolled at approximately 60 sites worldwide. Enrollment in the observational study will be monitored in an effort to achieve at least 20% (and no more than 80%) of the population receiving stents as the initial treatment strategy. Follow-up visits by sites will be reported at 6 and 12 months after index procedure to collect data on treatment patterns and effectiveness, and outcomes. The follow-up procedures are not mandated by the registry protocol. Each site will be encouraged to enter follow-up information derived from clinically indicated follow-up visits. All events post-index procedure till the 7th month will be reported under the 6 month follow-up form and subsequent follow-up till the 13th month post-procedure will be entered on the 12 month follow-up form.
Patient management and treatment decisions are at the discretion of the care team per routine clinical practice. The procedural aspects (including selection of stent type or non-stent based treatments) and follow-up are not mandated by the registry and will be up to the discretion of the operator and/or based upon the practice dictated by the clinical care of the patient. Therefore the study poses minimal risk to the patient. Read Less
Gender:
ALL
Ages:
All
Trial Updated:
12/05/2023
Locations: Arkansas Heart Institute, Little Rock, Arkansas
Denver VAMC, Denver, Colorado
Conditions: Peripheral Arterial Disease
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
Recruiting
The purpose of this study is to compare two biologic methods for the treatment of articular cartilage defects in the knee. The first method, microfracture, is the standard of care and is routinely used to recruit cells from the subchondral bone marrow to the site of cartilage loss. The second method is the application of adipose-derived stem cells (ADSCs) to the defect site. In theory, ADSCs on a collagen scaffold should enable the delivery of more specific progenitor cells to the site of injury... Read More
The purpose of this study is to compare two biologic methods for the treatment of articular cartilage defects in the knee. The first method, microfracture, is the standard of care and is routinely used to recruit cells from the subchondral bone marrow to the site of cartilage loss. The second method is the application of adipose-derived stem cells (ADSCs) to the defect site. In theory, ADSCs on a collagen scaffold should enable the delivery of more specific progenitor cells to the site of injury, resulting in better regeneration and integration of articular cartilage at the site of a defect as compared to the microfracture method. Read Less
Gender:
ALL
Ages:
Between 18 years and 50 years
Trial Updated:
04/24/2024
Locations: Stanford Medical Outpatient Center, Redwood City, California
UC Health Steadman Hawkins Clinic - Denver Inverness, Denver, Colorado
Conditions: Degenerative Lesion of Articular Cartilage of Knee
Blood Samples for the Study of Peanut, Tree Nut and Other Food Allergies
Recruiting
Food allergies are now a major problem. These experiments involve getting blood from people with food allergies and from people without food allergies. The blood collected will be used to answer questions and find information about peanut and other food allergies.
Samples will come from:
* People signed up by the investigators at the University of Colorado Denver
* University of North Carolina, Massachusetts General Hospital, Children's Hospital of Colorado and the Immune Tolerance Network (Be... Read More
Food allergies are now a major problem. These experiments involve getting blood from people with food allergies and from people without food allergies. The blood collected will be used to answer questions and find information about peanut and other food allergies.
Samples will come from:
* People signed up by the investigators at the University of Colorado Denver
* University of North Carolina, Massachusetts General Hospital, Children's Hospital of Colorado and the Immune Tolerance Network (Benaroya Research Institute) where people have been treated for peanut allergies
* University of North Carolina, Massachusetts General Hospital, National Jewish Health and The Children's Hospital in Denver where people have taken part or will take part in clinically indicated oral food challenges.
Blood and health histories from the University of North Carolina, Massachusetts General Hospital, National Jewish Health, The Children's Hospital and the Immune Tolerance Network will not have personal information linked.
The specific aims of this experiment are:
1. Come up with a lab test that will predict how bad an allergic reaction will be to peanuts.
2. Find out what part of a peanut causes allergic reactions.
3. Come up with preventions that can block peanut allergies.
4. Find the strongest proteins in walnuts. Read Less
Gender:
ALL
Ages:
Between 1 year and 75 years
Trial Updated:
12/14/2022
Locations: University of Colorado School of Medicine, Denver, Colorado
University of Colorado School of Medicine, Denver, Colorado
Conditions: Peanut Allergies, Tree Nut Allergies, Other Food Allergies
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Recruiting
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-sma... Read More
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/29/2024
Locations: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama +11 locations
Cancer Center of Colorado at Sloan's Lake, Denver, Colorado
Denver Health Medical Center, Denver, Colorado
Kaiser Permanente-Franklin, Denver, Colorado
National Jewish Health-Main Campus, Denver, Colorado
The Women's Imaging Center, Denver, Colorado
Porter Adventist Hospital, Denver, Colorado
Colorado Blood Cancer Institute, Denver, Colorado
Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado
Rocky Mountain Cancer Centers-Midtown, Denver, Colorado
SCL Health Saint Joseph Hospital, Denver, Colorado
Rocky Mountain Cancer Centers-Rose, Denver, Colorado
Rose Medical Center, Denver, Colorado
Conditions: ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II Non-Small Cell Lung Cancer AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7, Stage IIIA Non-Small Cell Lung Cancer AJCC v7
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
Recruiting
This is a first-in-human study evaluating the anti-T cell immunoglobulin and mucin containing protein-3 (TIM-3) antibody TSR-022. The study will be conducted in 2 parts with Part 1 consisting of dose escalation and Part 2 dose expansion. Part 1 will determine the recommended Phase 2 dose (RP2D) of TSR-022 and Part 2 will evaluate the antitumor activity of TSR-022 in combination with TSR-042 or docetaxel and as monotherapy.
This is a first-in-human study evaluating the anti-T cell immunoglobulin and mucin containing protein-3 (TIM-3) antibody TSR-022. The study will be conducted in 2 parts with Part 1 consisting of dose escalation and Part 2 dose expansion. Part 1 will determine the recommended Phase 2 dose (RP2D) of TSR-022 and Part 2 will evaluate the antitumor activity of TSR-022 in combination with TSR-042 or docetaxel and as monotherapy. Read Less
Gender:
All
Ages:
18 years and above
Trial Updated:
03/14/2024
Locations: GSK Investigational Site, Goodyear, Arizona +1 locations
GSK Investigational Site, Denver, Colorado
GSK Investigational Site, Denver, Colorado
Conditions: Neoplasms
A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
Recruiting
The purpose of this study is to compare the efficacy, safety, and tolerability of ide-cel with lenalidomide (LEN) maintenance to that of LEN maintenance alone in adult participants with Newly Diagnosed Multiple Myeloma (NDMM) who have achieved a suboptimal response post autologous stem cell transplantation (ASCT).
The purpose of this study is to compare the efficacy, safety, and tolerability of ide-cel with lenalidomide (LEN) maintenance to that of LEN maintenance alone in adult participants with Newly Diagnosed Multiple Myeloma (NDMM) who have achieved a suboptimal response post autologous stem cell transplantation (ASCT). Read Less
Gender:
All
Ages:
18 years and above
Trial Updated:
05/01/2024
Locations: Banner MD Anderson Cancer Center, Gilbert, Arizona
Colorado Blood Cancer Institute, Denver, Colorado
Conditions: Multiple Myeloma
Interpreting Denver Demographic Information to Identify Paid Trials
Interpreting that data, paid clinical trials for healthy volunteers will primarily be for adult males in their early thirties. Females have practically the same opportunity. Keep in mind, studies commonly require diverse samples from which to draw data; it’s just that the preponderance of available studies will likely involve individuals from these demographic areas.
Denver CROs Healthy Participants Might Explore For Opportunities
With over a hundred CROs to choose from in Denver and surrounding area, it can be hard to narrow down your choice of healthy volunteer paid clinical trials. If you’re not sure where to begin, here are three local options you might want to consider:
Medical Trends in Denver That Have Influenced the Science
Beyond available CRO opportunities for volunteers in good health, the city is known for many breakthroughs in medicine. Such breakthroughs ultimately end up benefiting the world, and changing history. You can get paid, help advance associated medical science, and positively augment history simultaneously through CRO opportunities. Here are several contributions to medical science from Denver:
- Discoveries in Medicine Designed to Combat Childhood Conditions
- Denver Was and Is Ahead of the Curve as Regards Digital Health
- Breakthrough Treatments in Women’s Health
Denver CRO Trial Opportunities Healthy Volunteers Might Want to Consider
Whether you are looking to make history, contribute to medical science, or carve a niche in history, you’ve got options in and around Denver. The mile high city is a cultural center in the country, and has CROs in abundance. If you want, you can even get started today.